NMI-187 | Interleukin Related interleukin-related.com

Product Name :
NMI-187

Search keywords :
β-Yohimbine

drugId :
null

Target Vo:
Adrenergic receptors alpha-2

Target Vo Short Name :
ADRA2

Moa_Name:
Nitric oxide donors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Nitromed Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Erectile Dysfunction

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Nivolumab manufacturer
Anselamimab manufacturer
HtrA2 Antibody (YA726): HtrA2 Antibody (YA726) is a non-conjugated and Mouse origined monoclonal antibody about 49 kDa, targeting to HtrA2 (8G11). It can be used for WB,IP assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts